AI assistant
OMNICELL, INC. — Director's Dealing 2020
Nov 23, 2020
31980_dirs_2020-11-23_9e081e3e-a788-47f0-a2d3-908403083eb3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: OMNICELL, Inc (OMCL)
CIK: 0000926326
Period of Report: 2020-11-20
Reporting Person: LIPPS RANDALL A (Director, Chairman, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-11-20 | Common Stock | M | 2400 | — | Acquired | 154516 | Direct |
| 2020-11-20 | Common Stock | S | 2400 | $105.0142 | Disposed | 152116 | Direct |
| 2020-11-23 | Common Stock | M | 12600 | — | Acquired | 164716 | Direct |
| 2020-11-23 | Common Stock | S | 12600 | $105.3992 | Disposed | 152116 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-11-20 | Stock Options NQ (Right to Buy) | $34.02 | M | 2400 | Disposed | 2025-02-05 | Common Stock (2400) | Direct |
| 2020-11-23 | Stock Options NQ (Right to Buy) | $34.02 | M | 12600 | Disposed | 2025-02-05 | Common Stock (12600) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 152116 | Direct |
| Common Stock | 229113 | Indirect |
| Common Stock | 8303 | Indirect |
Footnotes
F1: Shares held in trust with Mr. Lipps' wife.
F2: Shares held in trust for the benefit of Mr. Lipps' children.
F3: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020.
F4: The price reported in Column 4 is the average price of $105.0142. The sold price range between $105.00 to $105.03. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: The price reported in Column 4 is the average price of $105.3992. The sold price range between $105.0050 to $105.9200. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.